SCHEMBL20848813

SCHEMBL20848813

N#Cc1ccc(-n2c3ccc(-c4ccccc4C#N)cc3c3cc(-c4ccccc4C#N)ccc32)c(-c2cc(-c3ccc(C(F)(F)F)cc3C(F)(F)F)ccc2-n2c3ccc(-c4ccccc4C#N)cc3c3cc(-c4ccccc4C#N)ccc32)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 6/20 0.41
PGR P06401 2/20 0.37
PTPN5 P54829 1/20 0.37
EDNRB P24530 1/20 0.36
EDNRA P25101 1/20 0.36
ALOX5AP P20292 3/20 0.35
FEN1 P39748 3/20 0.35
KIF11 P52732 1/20 0.34
NR3C1 P04150 1/20 0.34
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
GABRA1 P14867 3/20 0.34
GABRG2 P18507 3/20 0.34
GABRB3 P28472 3/20 0.34
GABRA5 P31644 3/20 0.34
GABRA3 P34903 3/20 0.34
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20848791 0.97 AR (0.39) ARPGRPTPN5EDNRBEDNRA
SCHEMBL20848723 0.96 AR (0.40) ARPGRPTPN5EDNRBEDNRA
SCHEMBL22985250 0.94 AR (0.44) ARPGRPTPN5ALOX5APFEN1
SCHEMBL20848728 0.94 AR (0.38) ARPGRPTPN5EDNRBEDNRA
SCHEMBL20849000 0.94 AR (0.38) ARPGRPTPN5EDNRBEDNRA
SCHEMBL22985531 0.93 ALOX5AP (0.41) ARPGRPTPN5ALOX5APFEN1
SCHEMBL22985077 0.93 ALOX5AP (0.41) ARPGREDNRBEDNRAALOX5AP
SCHEMBL20849137 0.93 AR (0.38) ARPGREDNRBEDNRAALOX5AP
SCHEMBL22985070 0.93 ALOX5AP (0.38) ARPGREDNRBEDNRAALOX5AP
SCHEMBL20848736 0.92 AR (0.41) ARPGRPTPN5EDNRBEDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10978646-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2021-04-13 US disclosed
US-20190097141-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2019-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10978646-B2 Organic molecules for use in optoelectronic devices OCIAD2, OCIAD1, POU2F1 AR 3706/4885PGR 3590/4885PTPN5 4494/4885
US-20190097141-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OCIAD2, OCIAD1, POU2F1 AR 3706/4885PGR 3590/4885PTPN5 4494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.